Enteral feeding tolerance during pharmacologic neuromuscular blockade

Nutr Clin Pract. 2023 Dec;38(6):1236-1246. doi: 10.1002/ncp.11045. Epub 2023 Jul 20.

Abstract

A common misperception is that critically ill patients who receive paralytic therapy will not tolerate enteral nutrition. As a result, some clinicians empirically withhold enteral feedings for critically ill patients who receive neuromuscular blocker pharmacotherapy (NMB). The intent of this review is to examine the evidence regarding enteral feeding tolerance for critically ill patients given NMB. Studies evaluating enteral feeding during paralytic therapy are provided and critiqued. Evidence examining enteral feeding tolerance during NMB is limited. Enteral feeding intolerance is more likely attributable to the underlying illnesses and concurrent opioid analgesia, sedation, and vasopressor therapies. Most critically ill patients can be successfully fed during NMB. Prokinetic pharmacotherapy may be warranted in some patients.

Keywords: critical illness; enteral nutrition; feeding tolerance; neuromuscular blockade.

Publication types

  • Review

MeSH terms

  • Critical Illness / therapy
  • Enteral Nutrition* / adverse effects
  • Humans
  • Infant, Newborn
  • Neuromuscular Blockade* / adverse effects